Search research articles
Contact Us
Filters
Showing results (101-110 of 149) with videos related to
Page
of 15
Sort By:
Neuroscience
|
May 30, 2001
Differential regulation of chromogranin A, chromogranin B and secretogranin II in rat brain by phencyclidine treatment
J Marksteiner, U Weiss, C Weis, et al.
Biological Psychiatry
|
June 1, 1996
CSF of neuroleptic-naive first-episode schizophrenic patients: levels of biogenic amines, substance P, and peptides derived from chromogranin A (GE-25) and secretogranin II (secretoneurin)
C Miller, R Kirchmair, J Troger, et al.
European Journal of Haematology
|
August 31, 2000
EORTC QLQ-C30 and FACT-BMT for the measurement of quality of life in bone marrow transplant recipients: a comparison
M Kopp, H Schweigkofler, B Holzner, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer
|
June 30, 2001
Use of alternative/complementary therapy in breast cancer patients--a psychological perspective
R Moschèn, G Kemmler, H Schweigkofler, et al.
Pharmacopsychiatry
|
March 1, 2007
Outcomes in schizophrenia outpatients treated with amisulpride or olanzapine
A Hofer, M A Rettenbacher, M Edlinger, et al.
Journal of Neurochemistry
|
September 13, 2003
Differential effects of phencyclidine application on secretogranin II expression in organotypic slices of rat prefrontal cortex
Josef K Hinterhoelzl, Kayvon Salimi, Christian Humpel, et al.
Psychological Medicine
|
April 18, 2013
Hyperprolactinemia in antipsychotic-naive patients with first-episode psychosis
A Riecher-Rössler, J K Rybakowski, M O Pflueger, et al.
The American Journal of Psychiatry
|
October 2, 2001
Association of olanzapine-induced weight gain with an increase in body fat
U Eder, B Mangweth, C Ebenbichler, et al.
Journal of Clinical Psychopharmacology
|
August 1, 1994
A multicenter double-blind trial of paroxetine versus amitriptyline in depressed inpatients
C H Stuppaeck, C Geretsegger, A B Whitworth, et al.
International Journal of Clinical Practice
|
July 14, 2007
Metabolic side effects of antipsychotic medication
A Tschoner, J Engl, M Laimer, et al.
Page
of 15
Search research articles
Search
Showing results (101-110 of 149) with videos related to
Sort By:
Page
of 15
Neuroscience
|
May 30, 2001
Differential regulation of chromogranin A, chromogranin B and secretogranin II in rat brain by phencyclidine treatment
J Marksteiner, U Weiss, C Weis, et al.
Biological Psychiatry
|
June 1, 1996
CSF of neuroleptic-naive first-episode schizophrenic patients: levels of biogenic amines, substance P, and peptides derived from chromogranin A (GE-25) and secretogranin II (secretoneurin)
C Miller, R Kirchmair, J Troger, et al.
European Journal of Haematology
|
August 31, 2000
EORTC QLQ-C30 and FACT-BMT for the measurement of quality of life in bone marrow transplant recipients: a comparison
M Kopp, H Schweigkofler, B Holzner, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer
|
June 30, 2001
Use of alternative/complementary therapy in breast cancer patients--a psychological perspective
R Moschèn, G Kemmler, H Schweigkofler, et al.
Pharmacopsychiatry
|
March 1, 2007
Outcomes in schizophrenia outpatients treated with amisulpride or olanzapine
A Hofer, M A Rettenbacher, M Edlinger, et al.
Journal of Neurochemistry
|
September 13, 2003
Differential effects of phencyclidine application on secretogranin II expression in organotypic slices of rat prefrontal cortex
Josef K Hinterhoelzl, Kayvon Salimi, Christian Humpel, et al.
Psychological Medicine
|
April 18, 2013
Hyperprolactinemia in antipsychotic-naive patients with first-episode psychosis
A Riecher-Rössler, J K Rybakowski, M O Pflueger, et al.
The American Journal of Psychiatry
|
October 2, 2001
Association of olanzapine-induced weight gain with an increase in body fat
U Eder, B Mangweth, C Ebenbichler, et al.
Journal of Clinical Psychopharmacology
|
August 1, 1994
A multicenter double-blind trial of paroxetine versus amitriptyline in depressed inpatients
C H Stuppaeck, C Geretsegger, A B Whitworth, et al.
International Journal of Clinical Practice
|
July 14, 2007
Metabolic side effects of antipsychotic medication
A Tschoner, J Engl, M Laimer, et al.
Page
of 15